Controversy looms over unified distribution

Tension is running high again between drug makers and wholesalers as 30 pharmaceutical firms, who received the second administrative disposition on suspicion of violating the current regulation to prohibit a direct dealing with general hospitals, filed a class action lawsuit against regional agencies of the Korea Food and Drug Administration.

The Korean Association of Pharmaceutical Wholesal...